These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38504551)

  • 21. Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Gazourian L; Rogers AJ; Ibanga R; Weinhouse GL; Pinto-Plata V; Ritz J; Soiffer RJ; Antin JH; Washko GR; Baron RM; Ho VT
    Am J Hematol; 2014 Apr; 89(4):404-9. PubMed ID: 24375545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial.
    Matthaiou EI; Sharifi H; O'Donnell C; Chiu W; Owyang C; Chatterjee P; Turk I; Johnston L; Brondstetter T; Morris K; Cheng GS; Hsu JL
    Bone Marrow Transplant; 2022 Aug; 57(8):1319-1326. PubMed ID: 35641662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
    Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
    Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.
    Soubani AO; Kingah P; Alshabani K; Muma G; Haq A
    Clin Transplant; 2014 Jul; 28(7):776-82. PubMed ID: 24754643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.
    Grønningsæter IS; Tsykunova G; Lilleeng K; Ahmed AB; Bruserud Ø; Reikvam H
    Expert Rev Clin Immunol; 2017 Jun; 13(6):553-569. PubMed ID: 28052713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.
    Brownback KR; Thomas LA; McGuirk JP; Ganguly S; Streiler C; Abhyankar S
    Lung; 2017 Dec; 195(6):781-788. PubMed ID: 28894914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical analysis of bronchiolitis obliterans syndrome after haplo- hematopoietic stem cell transplantation].
    Zhuang J; Gu B; Ke P; Liu YJ; Wu XJ; Xue SL; Hu XH; He XF; Ma X; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 May; 40(5):404-410. PubMed ID: 31207706
    [No Abstract]   [Full Text] [Related]  

  • 29. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakasone H; Kanda J; Yano S; Atsuta Y; Ago H; Fukuda T; Kakihana K; Adachi T; Yujiri T; Taniguchi S; Taguchi J; Morishima Y; Nagamura T; Sakamaki H; Mori T; Murata M;
    Transpl Int; 2013 Jun; 26(6):631-9. PubMed ID: 23551210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
    Au BK; Au MA; Chien JW
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bergeron A; Cheng GS
    Clin Chest Med; 2017 Dec; 38(4):607-621. PubMed ID: 29128013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
    Norman BC; Jacobsohn DA; Williams KM; Au BK; Au MA; Lee SJ; Moravec CK; Chien JW
    Bone Marrow Transplant; 2011 Oct; 46(10):1369-73. PubMed ID: 21132024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation.
    Kuroi T; Fujii N; Ichimura K; Seike K; Yamamoto A; Kambara Y; Sugimoto S; Otani S; Saeki K; Fujiwara H; Nishiomori H; Oto T; Maeda Y
    Int J Hematol; 2021 Dec; 114(6):701-708. PubMed ID: 34494183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation: Single-Center Experience.
    Işık Ö; Erol S; Cengiz Seval G; Gürün Kaya A; Toprak SK; Özdemir Kumbasar Ö
    Exp Clin Transplant; 2024 May; 22(5):373-380. PubMed ID: 38970280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline.
    Shanthikumar S; Gower WA; Srinivasan S; Rayment JH; Robinson PD; Bracken J; Stone A; Das S; Barochia A; Charbek E; Tamae-Kakazu M; Reardon EE; Abts M; Blinman T; Calvo C; Cheng PC; Cole TS; Cooke KR; Davies SM; De A; Gross J; Mechinaud F; Sheshadri A; Siddaiah R; Teusink-Cross A; Towe CT; Walkup LL; Yanik GA; Bergeron A; Casey A; Deterding RR; Liptzin DR; Schultz KR; Iyer NP; Goldfarb S
    Am J Respir Crit Care Med; 2024 Aug; 210(3):262-280. PubMed ID: 38889365
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.